DS
STRO icon

David Shaw’s Sutro Biopharma STRO Stock Holding History

David Shaw’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Buy
+30,128
New +$939K ﹤0.01% 3750
2025
Q2 		– Sell
-15,804
Closed -$103K – 4704
2025
Q1 		$103K Buy
15,804
+36
+0.2% +$567 ﹤0.01% 4013
2024
Q4 		$290K Sell
15,768
-997
-6% -$30.4K ﹤0.01% 3910
2024
Q3 		$580K Buy
16,765
+3,898
+30% +$153K ﹤0.01% 3612
2024
Q2 		$377K Sell
12,867
-11,297
-47% -$447K ﹤0.01% 3779
2024
Q1 		$1.37M Buy
+24,164
New +$1.07M ﹤0.01% 2894
2023
Q3 		– Sell
-4,072
Closed -$189K – 4485
2023
Q2 		$189K Sell
4,072
-11,448
-74% -$570K ﹤0.01% 3753
2023
Q1 		$717K Sell
15,520
-12,039
-44% -$764K ﹤0.01% 3372
2022
Q4 		$2.23M Sell
27,559
-3,942
-13% -$274K ﹤0.01% 2850
2022
Q3 		$1.75M Buy
31,501
+5,561
+21% +$329K ﹤0.01% 3118
2022
Q2 		$1.35M Buy
+25,940
New +$1.45M ﹤0.01% 3414
2022
Q1 		– Sell
-3,066
Closed -$456K – 5922
2021
Q4 		$456K Sell
3,066
-673
-18% -$121K ﹤0.01% 4454
2021
Q3 		$706K Buy
3,739
+841
+29% +$160K ﹤0.01% 3861
2021
Q2 		$539K Sell
2,898
-1,363
-32% -$267K ﹤0.01% 4003
2021
Q1 		$970K Sell
4,261
-5,602
-57% -$1.33M ﹤0.01% 3139
2020
Q4 		$2.14M Buy
+9,863
New +$1.63M ﹤0.01% 2512

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

David Shaw's STRO Position: Q2 2026 in Review

David Shaw opened a new position in Sutro Biopharma (STRO) in Q2 2026: 30,128 shares worth $1M. The stake represents ﹤0.01% of the portfolio and ranks #3750 among its holdings. This is a return to the name: David Shaw previously reported a position in STRO as recently as Q1 2025.

David Shaw first reported a position in STRO in Q4 2020 and has held it in 16 quarters since. The position peaked at $2.23M in Q4 2022. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • David Shaw held 30,128 shares of Sutro Biopharma worth $1M as of Q2 2026.
  • Sutro Biopharma was a new David Shaw position in Q2 2026.
  • Sutro Biopharma made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3750 holding.
  • David Shaw first reported a position in Sutro Biopharma in Q4 2020 and has held it in 16 quarters since.
  • David Shaw's Sutro Biopharma position peaked at $2.23M in Q4 2022.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.